Frovatriptan Succinate Patent Expiration
Frovatriptan Succinate is Used for the acute treatment of migraine attacks in adults. It was first introduced by Endo Operations Ltd
Frovatriptan Succinate Patents
Given below is the list of patents protecting Frovatriptan Succinate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Frova | US5464864 | Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists |
Nov 07, 2015
(Expired) | Endo Operations |
| Frova | US5827871 | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
Oct 27, 2015
(Expired) | Endo Operations |
| Frova | US5637611 | Medicaments |
Jun 10, 2014
(Expired) | Endo Operations |
| Frova | US5616603 | Enantiomers of carbazole derivatives as 5-HT1 -like agonists |
Apr 01, 2014
(Expired) | Endo Operations |
| Frova | US5962501 | Enantiomer of carbazole derivative as 5-HT1-like agonists |
Dec 16, 2013
(Expired) | Endo Operations |
Frovatriptan Succinate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List